FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology and represents a method for preparing virus-like particles containing hepatitis C virus core, E1 and E2 structural antigens, and a method for particle purification. The method for preparing the virus-like particles involves Hansenula polymorpha yeast cell transformation with a recombinant plasmid containing one open reading frame carrying hepatitis C virus core-E1-E2 genes a direct expression of which leads to the formation of core, E1 and E2 antigens. That is followed by culturing and recovering the prepared particles. A method for virus-like particle purification involves bleaching of a damaged cell homogenate, diafiltration, concentration, precipitation with low pH, ion-exchange chromatography, sedimentation centrifugation in a density gradient, hydrophobic chromatography and gel chromatography.
EFFECT: invention enables preparing the high-yield virus-like particles applicable as a vaccine for preventing and/or treating the diseases caused by hepatitis C virus.
2 cl, 5 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
POLYEPITOPIC ANTI-HEPATITIS B VACCINE OF 4-TH GENERATION AND METHOD OF OBTAINING IT | 2011 |
|
RU2469741C1 |
RECOMBINANT VACCINE FOR PREVENTION OF VIRAL HEPATITIS E IN ANIMALS | 2012 |
|
RU2501568C1 |
RECOMBINANT Hansenula polymorpha YEAST STRAIN - PRODUCER OF HEPATITIS B VIRUS SURFACE ANTIGEN SEROTYPE "ayw" | 2015 |
|
RU2586511C1 |
RECOMBINANT Hansenula polymorpha YEAST STRAIN - PRODUCER OF MUTANT HEPATITIS B VIRUS SURFACE ANTIGEN (VERSIONS) | 2015 |
|
RU2586513C1 |
METHOD FOR OBTAINING RECOMBINANT CORE PROTEIN OF HEPATITIS E VIRUS AND RECOMBINANT VACCINE FOR PROPHYLAXIS OF HEPATITIS E VIRUS | 2012 |
|
RU2501809C1 |
RECOMBINANT STRAIN OF YEAST HANSENULA POLYMORPHA - PRODUCENT OF CAPSID PROTEIN OF HEPATITIS E VIRUS | 2012 |
|
RU2493249C1 |
RECOMBINANT VACCINE FOR PROPHYLAXIS OF HEPATITIS B (VERSIONS) | 2015 |
|
RU2603729C2 |
METHOD OF OBTAINING A RECOMBINANT VACCINE FOR PREVENTION OF HUMANPAPILLOMA VIRUS INFECTION, RECOMBINANT VACCINE | 2018 |
|
RU2681174C1 |
RECOMBINANT VACCINE FOR PREVENTION OF HUMAN PAPILLOMAVIRUS INFECTION AND METHOD OF ITS PREPARATION | 2014 |
|
RU2546243C1 |
ISOLATED ENVELOPE HCV PROTEIN, METHOD FOR ITS PREPARING AND DRUG, VACCINE, PHARMACEUTICAL COMPOSITION (VARIANTS) COMPRISING THEREOF | 2002 |
|
RU2274643C2 |
Authors
Dates
2014-04-10—Published
2012-08-01—Filed